476 related articles for article (PubMed ID: 24816130)
1. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles.
Andrade LM; de Fátima Reis C; Maione-Silva L; Anjos JL; Alonso A; Serpa RC; Marreto RN; Lima EM; Taveira SF
Eur J Pharm Biopharm; 2014 Sep; 88(1):40-7. PubMed ID: 24816130
[TBL] [Abstract][Full Text] [Related]
2. Improved tacrolimus skin permeation by co-encapsulation with clobetasol in lipid nanoparticles: Study of drug effects in lipid matrix by electron paramagnetic resonance.
Andrade LM; Silva LAD; Krawczyk-Santos AP; Amorim ICSM; Rocha PBRD; Lima EM; Anjos JLV; Alonso A; Marreto RN; Taveira SF
Eur J Pharm Biopharm; 2017 Oct; 119():142-149. PubMed ID: 28627400
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
5. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E
J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033
[TBL] [Abstract][Full Text] [Related]
7. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R
Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282
[TBL] [Abstract][Full Text] [Related]
8. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
9. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
11. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
J Microencapsul; 2009 Dec; 26(8):734-47. PubMed ID: 19888882
[TBL] [Abstract][Full Text] [Related]
12. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M
Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
[TBL] [Abstract][Full Text] [Related]
14. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
15. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
16. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications.
Suter F; Schmid D; Wandrey F; Zülli F
Eur J Pharm Biopharm; 2016 Nov; 108():304-309. PubMed ID: 27343822
[TBL] [Abstract][Full Text] [Related]
17. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite.
Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M
Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163
[TBL] [Abstract][Full Text] [Related]
18. Development and in vitro evaluation of lipid nanoparticle-based dressings for topical treatment of chronic wounds.
Gainza G; Chu WS; Guy RH; Pedraz JL; Hernandez RM; Delgado-Charro B; Igartua M
Int J Pharm; 2015 Jul; 490(1-2):404-11. PubMed ID: 26043822
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
Khurana S; Bedi PM; Jain NK
Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
[TBL] [Abstract][Full Text] [Related]
20. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
Elnaggar YS; El-Massik MA; Abdallah OY
Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
